Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein Toxicity
Silke Nuber, Chee Yeun Chung, Daniel F. Tardiff, et al.
Neurotherapeutics (2022) Vol. 19, Iss. 3, pp. 1018-1036
Open Access | Times Cited: 12

Showing 12 citing articles:

Targeting de novo lipid synthesis induces lipotoxicity and impairs DNA damage repair in glioblastoma mouse models
Katharina M. Eyme, Alessandro Sammarco, Roshani Jha, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 679
Open Access | Times Cited: 35
Driving factors of neuronal ferroptosis
Julie Jacquemyn, Isha Ralhan, Maria S. Ioannou
Trends in Cell Biology (2024) Vol. 34, Iss. 7, pp. 535-546
Closed Access | Times Cited: 13
Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions
Isabel Lam, Alain Ndayisaba, Amanda J. Lewis, et al.
Neuron (2024) Vol. 112, Iss. 17, pp. 2886-2909.e16
Open Access | Times Cited: 10
Generation of G51D and 3D mice reveals decreased α-synuclein tetramer-monomer ratios promote Parkinson’s disease phenotypes
Silke Nuber, Xiaoqun Zhang, Thomas D. McCaffery, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Sulfamerazine as a Potential Modulator against α-Synuclein Aggregation and Associated Toxicity
Priyanka Singh, Nagesh Y. Kadam, Rajlaxmi Panigrahi, et al.
ACS Chemical Neuroscience (2025) Vol. 16, Iss. 5, pp. 880-894
Closed Access
Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson’s patients
Laura de Boni, Amber Wallis, Aurelia Hays Watson, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 7, pp. 1657-1674
Open Access | Times Cited: 2
Reducing the lipase LIPE in mutant α-synuclein mice improves Parkinson-like deficits and reveals sex differences in fatty acid metabolism
Marie-Alexandre Adom, Wolf N. Hahn, T.D. McCaffery, et al.
Neurobiology of Disease (2024) Vol. 199, pp. 106593-106593
Open Access | Times Cited: 2
Increased palmitoylation improves estrogen receptor alpha–dependent hippocampal synaptic deficits in a mouse model of synucleinopathy
Tim E. Moors, Shaomin Li, Thomas D. McCaffery, et al.
Science Advances (2023) Vol. 9, Iss. 46
Open Access | Times Cited: 5
Interaction between α-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies
Chiara Sanluca, P. Spagnolo, Romina Mancinelli, et al.
Metabolites (2024) Vol. 14, Iss. 7, pp. 352-352
Open Access | Times Cited: 1
Identification of Glycerol 3-phosphate acyltransferase as a potent modifier of α-Synuclein-induced toxicity
Kah‐Leong Lim, Mengda Ren, Gui Yin Grace Lim, et al.
Research Square (Research Square) (2024)
Open Access
Nazo, the Drosophila homolog of the NBIA-mutated protein – c19orf12, is required for triglyceride homeostasis
Perinthottathil Sreejith, Sara Lolo, Kristen R. Patten, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Future Advances in Early Phase Clinical Development for Disease Modifying Therapies for Neurodegenerative Diseases
Philip Kremer, Geert Jan Groeneveld
Medical Research Archives (2022) Vol. 10, Iss. 9
Open Access
Page 1

Scroll to top